What is the advantage of testing for six cancer types simultaneously versus separate tests for each?

Six separate cancer screenings would require: a PSA test (prostate), mammogram (breast), colonoscopy or Cologuard (colorectal), CA-125 + transvaginal ultrasound (ovarian), low-dose CT (lung), and no standard test yet for pancreatic cancer. The combined cost of these screenings can exceed $3,000–$5,000 including facility fees. They require multiple clinic visits, different sample types (blood, urine, stool, imaging), different preparation requirements, and different specialists. OncuraKit screens for all six cancer types simultaneously from a single 10 mL urine sample, at home, for $995 — and does so with a Stage I sensitivity that exceeds most of these traditional single-organ tests. The multi-cancer simultaneous approach is not just more convenient — it is fundamentally more clinically efficient.